University of California San Francisco
Displaying 2581 - 2610 of 16971
-
-
Archive: Nature Publication Presents New ‘Blueprint’ Revealing How SARS-CoV-2 Virus Hijacks Human Cells
An international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug compounds on SARS-CoV-2, the virus that causes COVID-19.
-
Archive: Experts Explain How Contact Tracing Will End the Coronavirus Pandemic
To ramp up contact tracing for COVID-19 in San Francisco, UCSF has been partnering with the San Francisco Department of Public Health (SFDPH) to provide technical assistance, training and manpower.
-
Archive: Bay Area COVID-19 Testing Initiative to Assess Impact, Guide Safe Reopening of California Economy
A new large-scale, long-term research collaboration aims to better understand the spread of COVID-19 across the San Francisco Bay Area.
-
Archive: UCSF Health Re-Opens Mount Zion Hospital for Inpatient Care
UCSF Health has opened 13 acute- and critical-care beds at its Mount Zion hospital as the first phase of a new, 53-bed respiratory isolation unit that will serve as UCSF Health’s primary site for
-
Archive: Two UCSF Faculty Elected to National Academy of Sciences in 2020
The two from UCSF are among 120 new members elected to the Academy in 2020.
-
Archive: Elena Fuentes-Afflick Elected to American Academy of Arts and Sciences
UCSF pediatrician and epidemiologist, Elena Fuentes-Afflick, MD, MPH, has been elected to the American Academy of Arts and Sciences, which honors exceptional scholars, leaders, artists and innovators. Fuentes-Afflick’s research has focused on the issues of acculturation, immigrant health and health disparities.
-
Archive: Testing the Tests: COVID-19 Antibody Assays Scrutinized for Accuracy by UCSF, UC Berkeley Researchers
A project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.
-
Archive: Has Coronavirus Been in California Since the Fall? Researchers Investigate
-
Archive: Coronavirus Antibody Tests: Can You Trust the Results?
-
Archive: BRIDGE Tool Helps to Bring Precision Medicine Into the Clinic
BRIDGE is an interface available to physicians during their encounter with patients.
-
Archive: Two Drugs Studied in Bay Area Could Lessen Coronavirus Deaths, Hospitalizations
-
Archive: The Promise and Uncertainties of Antibody Testing for Coronavirus
As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody testing as a way to identify people who have developed immunity to the virus. UCSF experts explain how antibody testing works, who it can be most useful for and why we should be cautious.
-
Archive: ‘Designer Virus’ is First New Polio Vaccine in 50 Years
A UCSF researcher is among the team that announced promising Phase 1 clinical results for the first new oral polio vaccine in 50 years.
-
Archive: UCSF School of Pharmacy Faculty Member Describes Being a COVID-19 Patient
Marilyn Stebbins, a UCSF School of Pharmacy faculty member, shares a firsthand account of being a COVID-19 patient.
-
Archive: UCSF Health Care Workers to Serve in Navajo Nation
The UCSF health care workers specialize in critical care, intensive care, acute care and hospital medicine.
-
Archive: Older and Stuck at Home? Expert Advice on Fitness
-
Archive: COVID-19 Arrived in Seattle. Where It Went From There Stunned the Scientists.
-
Archive: COVID-19 Testing in Mission District, Bolinas to Inform Next Steps in Fight Against Disease
UCSF infectious disease researchers and community partners have launched an effort to provide comprehensive, voluntary COVID-19 testing to all residents of two distinctive Bay Area communities.
-
Archive: What We Know, and Don't Know, A Month into Bay Area's Coronavirus Shelter-in-Place Order
-
Archive: Hand Sanitizer for the People: The Allyship of an Actor and PhD Student
-
Archive: Clinical Trial Testing If Common Anti-Inflammatory Drug Reduces Hospitalization, Death Caused by Coronavirus
UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
-
Archive: CRISPR and Spit Might Be Keys to Faster, Cheaper, Easier Tests for the Coronavirus
-
Archive: CRISPR-Based ‘Discovery Engine’ for New Cell Therapies to Advance Cancer Treatments
UCSF researchers now have reported a new method to design and test cell therapies, one they expect will speed the development of new life-saving treatments not only for cancer, but for other diseases, too.
-
Archive: UCSF Offering Free COVID-19 Test Analysis, Results to Public Health Departments of All 58 California Counties
UCSF is announcing that it will provide free COVID-19 sample analysis, indefinitely, to all California Departments of Public Health.
-
Archive: Is Herd Immunity a Solution to the Coronavirus Pandemic?
-
Archive: UCSF Team of Scientists Produces, Distributes Hand Sanitizer for Bay Area's Incarcerated, Most Vulnerable Populations
The Science Policy Group at UCSF has initiated a project to provide alcohol-based hand sanitizer to incarcerated populations, as well as people living in public or transitional housing or experiencing homelessness, with plans to distribute 15,000 bottles.
-
Archive: New CRISPR-Based COVID-19 Test Kit Can Diagnose Infection in Less Than an Hour
While the widely used coronavirus PCR tests take about four hours to produce a result from a respiratory sample, the new DETECTR test developed by UCSF scientists takes only 45 minutes, rapidly accelerating the pace of diagnosis.
-
Archive: Video: Emergency Care Doctor Explains When to Wear a Face Mask, How to Do It the Right Way
We asked UCSF emergency care physician Jeanne Noble to explain why everyone should wear a face mask and to demonstrate step-by-step how to safely don and doff masks of different types.
-
Archive: More Steps Needed to Manage Current Care of Older Adults
The COVID-19 pandemic is a critical time to think about how best to manage the care of older adults, both for their sake and for the near- and longer-term costs and stresses to the health care system, according to a new commentary by a UCSF clinician.
